Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study will compare the response of subjects who failed a first-line ATV-containing
regimen and who have the 150L-containing virus to subsequent protease inhibitor
(PI)-containing therapy with that of a cohort who has failed a first-line reverse
transcriptase inhibitor (NNRTI), and is subsequently receiving PI-containing therapy.